Barinthus Biotherapeutics PLC Sponsored ADR (BRNS)
(Delayed Data from NSDQ)
$2.34 USD
-0.02 (-0.64%)
Updated May 10, 2024 03:57 PM ET
After-Market: $2.32 -0.02 (-0.64%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Brokerage Reports
0 items in cart
Barinthus Biotherapeutics PLC Sponsored ADR [BRNS]
Reports for Purchase
Showing records 1 - 4 ( 4 total )
Company: Barinthus Biotherapeutics PLC Sponsored ADR
Industry: Medical - Biomedical and Genetics
2023 Financial Results Reported; Reiterate Buy; Lowering PT to $8
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: Barinthus Biotherapeutics PLC Sponsored ADR
Industry: Medical - Biomedical and Genetics
Multiple Data Readouts Expected in 1H24; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: Barinthus Biotherapeutics PLC Sponsored ADR
Industry: Medical - Biomedical and Genetics
New Partnership Inked on Vaccine Against MERS-CoV; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: Barinthus Biotherapeutics PLC Sponsored ADR
Industry: Medical - Biomedical and Genetics
Promising Interim Data from HBV Trials Presented; 3Q23 Results; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
|